5,6,11

Subdecks (3)

Cards (307)

  • Psychosis
    A mental disorder involving a loss of contact with reality, may be due to increased level of dopamine in the brain
  • Two broad forms of psychosis
    • Hallucination - hearing, seeing and feeling things that are not existing
    • Delusion - holding unusual belief that are not shared by other people
  • Psychotic Disorders
    • Schizophrenia
    • Manic Phase of Bipolar Illness
    • Acute Idiopathic Psychotic Illness
  • Schizophrenia
    The most common psychotic disorder, perception, thinking, communication, social functioning, and attention are altered, characterized by a clear sensorium but a marked thinking disturbance
  • Symptoms of Schizophrenia
    • Positive - delusion, hallucination, restlessness, and talking with own self
    • Negative - loss of motivation, cognitive impairment, akinesia, mental depression, social withdrawal, reduced sexual urge, flat affect & apathy, and monotonic speech
  • Neurotransmitter Abnormalities in Schizophrenia
    • Dopamine
    • Serotonin
    • Glutamate
  • Stages of Schizophrenia
    • Prodromal - unhygienic, loss interest in work, gradual
    • Acute - full blown of psychotic behavior, with + or - symptoms
    • Stabilization - symptoms gradually lessen
    • Stable - disappearance of symptoms
  • Psychosis
    A mental disorder involving a loss of contact with reality
  • Psychosis
    • May be due to the increased level of dopamine in the brain
  • Two broad forms of psychosis
    • Hallucination
    • Delusion
  • Hallucination
    Hearing, seeing and feeling things that are not existing
  • Delusion
    Holding unusual belief that are not shared by other people
  • Psychotic disorders
    • Schizophrenia
    • Manic Phase of Bipolar Illness
    • Acute Idiopathic Psychotic Illness
  • Schizophrenia
    • The most common psychotic disorder
    • Perception, thinking, communication, social functioning, and attention are altered
    • Characterized by a clear sensorium but a marked thinking disturbance
  • Symptoms of schizophrenia
    • Positive symptoms: delusion, hallucination, restlessness, and talking with own self
    • Negative symptoms: loss of motivation, cognitive impairment, akinesia, mental depression, social withdrawal, reduced sexual urge, flat affect & apathy, and monotonic speech
  • Neurotransmitter abnormalities in schizophrenia
    • Dopamine
    • Serotonin
    • Glutamate
  • Stages of schizophrenia
    • Prodromal: unhygienic, loss interest in work, gradual
    • Acute: full blown of psychotic behavior, with + or - symptoms
    • Stabilization: symptoms gradually lessen
    • Stable: disappearance of symptoms
  • Risk factors for schizophrenia
    • Environmental factors
    • Genetics
    • Poverty
    • At birth
    • Stress
    • Birth on winter
    • Drug abuse
  • Two major types of antipsychotic drugs
    • Typical
    • Atypical
  • Typical antipsychotics
    • Treat positive symptoms
    • Block Dopamine receptors only
    • Increased Extrapyramidal Symptoms (EPS)
    • Cheaper
    • Conventional/first-generation agents
  • Examples of typical antipsychotics
    • Phenothiazines
    • Butyrophenones
    • Thioxanthene
  • Extrapyramidal symptoms
    • Dystonia: sustained contraction of muscles leading to twisting, distorted postures (occurs after few hours or days of tx)
    • Akathisia: motor restlessness (days to weeks of tx)
    • Pseudoparkinsonism: weeks to months of initial tx
    • Tardive dyskinesia: may be irreversible, months or years of tx; involuntary movements, usually of the tongue, lips, neck, trunk and limbs
  • Atypical antipsychotics
    • Treat both positive & negative symptoms
    • Decreased EPS
    • Block dopamine & serotonin receptors (5-HT2A)
    • More expensive
    • Second generation agents
    • First line antipsychotics
  • Examples of atypical antipsychotics
    • Loxapine
    • Clozapine
    • Risperidone
    • Sertindole
    • Olanzapine
    • Quetiapine
    • Aripiprazole
  • Complications of atypical antipsychotics
    • Abdominal fat
    • Hypertension
    • Hyperlipidemia
    • Diabetes
    • Insulin Resistance
  • Actions of antipsychotics
    • Antipsychotic effects
    • Extrapyramidal effects
    • Antiemetic (except Aripiprazole)
    • Anticholinergic
  • Phenothiazines
    Have a tricyclic structure in which two benzene rings are linked by a sulfur and a nitrogen atom
  • Types of phenothiazines
    • Aliphatic - Chlorpromazine
    • Piperazine - Fluphenazine, Prochlorperazine
    • Piperidine - Thioridazine
  • Chlorpromazine
    First phenothiazine compound introduced in therapy, used to treat intractable hiccups
  • Phenothiazine drugs

    • Promazine
    • Triflupromazine
    • Thioridazine
    • Prochlorperazine
    • Mesoridazine
    • Perphenazine
    • Fluphenazine
  • Thiothixene
    Differs from the phenothiazine system by replacement of the N-H moiety with a carbon atom doubly bonded to the propylidine side chain
  • Butyrophenone drugs
    • Haloperidol
    • Droperidol
  • Haloperidol
    A potent antipsychotic useful in schizophrenia and in psychoses associated with brain damage, frequently chosen to terminate mania and often used in therapy for Gilles de la Tourette
  • Atypical antipsychotic drugs
    • Loxapine
    • Clozapine
    • Olanzapine
    • Quetiapine
  • Clozapine
    Has proved effective even in chronically ill patients who respond poorly to standard neuroleptics, but has severe side effects of agranulocytosis and agranulocytosis
  • Olanzapine
    A more potent antagonist at D2 and 5-HT2A receptors, can induce weight gain, type 2 diabetes & hyperlipidemia
  • Other atypical antipsychotic drugs
    • Risperidone
    • Ziprasidone
    • Aripiprazole
  • Aripiprazole
    Newest antipsychotic agent, dopamine agonist-antagonist with lesser weight gain
  • Cholinergic antagonists
    Agents that bind to cholinoceptors (muscarinic or nicotinic) and prevent the effects of acetylcholine (ACh) and other cholinergic agonists
  • Anticholinergic agents

    Also known as antimuscarinic agents or parasympatholytics, selective blockers of muscarinic receptors